PFE : Summary for Pfizer, Inc. - Yahoo Finance

U.S. Markets close in 1 hr 30 mins

Pfizer Inc. (PFE)


NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
34.06-0.23 (-0.67%)
As of 2:30PM EDT. Market open.
People also watch
MRKJNJJPMGEINTC
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close34.29
Open34.27
Bid34.21 x 1000
Ask34.49 x 400
Day's Range33.95 - 34.27
52 Week Range29.41 - 37.39
Volume15,425,938
Avg. Volume25,073,271
Market Cap202.83B
Beta1.04
PE Ratio (TTM)29.04
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.28 (3.71%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Barrons.com2 hours ago

    Healthcare: Will They or Won't They?

    The Health Care Select Sector SPDR exchange-traded fund (XLV) has gained 0.31% on news that the vote count for the health care bill  was trending "yes" according to House GOP Whip Rep. Markwayne ...

  • TheStreet.com3 hours ago

    Mylan Hit After Abbott Dumps Shares

    The company decreased its 13% stake in Mylan Friday.

  • Pfizer's Immunotherapy for Skin Cancer Gets FDA Approval
    Zacks3 hours ago

    Pfizer's Immunotherapy for Skin Cancer Gets FDA Approval

    Pfizer, Inc. (PFE) and German partner Merck KGaA's investigational cancer treatment, avelumab, was approved by the FDA for the treatment of metastatic Merkel cell carcinoma (MCC), a rare and aggressive form of skin cancer.